This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents. Top assignee: Vicuron Pharmaceuticals Inc.. Active years: 2005-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2009
Title: Jason G Lewis: Innovator in Antibacterial Compounds
Introduction
Jason G Lewis is a prominent inventor based in Hayward, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 7 patents to his name, Lewis has established himself as a key figure in innovation within the pharmaceutical industry.
Latest Patents
Among his latest patents, Lewis has developed pyrrolidine bicyclic compounds and their derivatives. These compounds have interesting properties, particularly in the treatment or prevention of disorders that can be addressed by PDF inhibitors, such as bacterial infections. Another notable patent involves lincomycin derivatives that exhibit antibacterial activity. These novel lincomycin derivatives may show potent activities against bacteria, including Gram-positive organisms, making them useful antimicrobial agents. The methods of synthesis and use of these compounds are also disclosed in his patents.
Career Highlights
Lewis is currently associated with Vicuron Pharmaceuticals Inc., where he continues to innovate and contribute to the development of new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of bacterial infections through innovative compounds.
Collaborations
Lewis has collaborated with notable colleagues in his field, including Dinesh Vinoobhai Patel and Mikhail Fedorovich Gordeev. These collaborations have further enhanced the research and development efforts within the pharmaceutical sector.
Conclusion
Jason G Lewis is a distinguished inventor whose work in antibacterial compounds has the potential to significantly impact the treatment of bacterial infections. His innovative contributions and collaborations continue to drive advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile